The cyclohexane tolerance and Phe-Arg-b-naphtylamide susceptibility of multidrug- resistant Enterobacter cloacae clinical isolates, and the predominance.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan  H. Ando, S. Mitarai, Y. Kondo, T. Suetake, J.-I. Sekiguchi,
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
J. Engberg, D. D. Bang, R. Aabenhus, F. M. Aarestrup, V. Fussing, P
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,
Characteristics of Clostridium difficile strains isolated from asymptomatic individuals and from diarrheal patients  S. Wongwanich, P. Pongpech, C. Dhiraputra,
Gut bacterial microbiota and obesity
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Salmonella genomic island 1-J variants associated with change in the antibiotic resistance gene cluster in multidrug-resistant Salmonella enterica serovar.
Migrant health—a cause for concern?
K. Diestra, E. Miró, C. Martí, D. Navarro, J. Cuquet, P. Coll, F
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.
Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST- complexes 38 and 448, and ST131 in Norway  U. Naseer, B. Haldorsen,
Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland  M. Eklund, M. Bielaszewska, U.-M. Nakari,
D.S. Hansen, R. Skov, J.V. Benedí, V. Sperling, H.J. Kolmos 
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
Vector control: a cornerstone in the malaria elimination campaign
E. Tortoli, P. G. Rogasi, E. Fantoni, C. Beltrami, A. De Francisci, A
Emergence of resistance to fluoroquinolones and third-generation cephalosporins in Shigella flexneri subserotype 1c isolates from China  S. Qiu, X. Xu,
Breast milk causing neonatal sepsis and death
Sofie Arens, Jan Verhaegen, Ludo Verbist 
C. Peña, M.A. Dominguez, M. Pujol, R. Verdaguer, F. Gudiol, J. Ariza 
Mechanisms of quinolone resistance in clinical isolates of Enterobacter cloacae  Apostolos Georgopoulos, Robert Schein, Astrid Buxbaum, Susan Tzotzos,
Training for the infectious diseases speciality in Norway
E.C. Böttger  Clinical Microbiology and Infection 
Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan  L.-Y. Huang, T.-L. Chen, P.-L. Lu, C.-A. Tsai,
Cephalosporins: a pharmacological update
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia  A. Budimir, R.H. Deurenberg, Z. Bošnjak,
Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.
Metagenomics and probiotics
C. Silva-Costa, F.R. Pinto, M. Ramirez, J. Melo-Cristino 
Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals  E.E. Udo, N. Al-Sweih, B.
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen 
Update on antifungal resistance in Aspergillus and Candida
Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital  A. Verroken,
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals  G.L. Cartolano,
P.M. Hawkey  Clinical Microbiology and Infection 
Endemic meningococcal disease in Cerdanyola, Spain, 1987–93: molecular epidemiology of the isolates of Neisseria meningitidis  M. Esther Verdú, Pere Coll,
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis  C.C. Naidoo, M. Pillay  Clinical.
Clinical Microbiology and Infection
Comparison of macrorestriction analysis of genomic DNA by pulsed-field gel electrophoresis and ribotyping with conventional methods for differentiation.
Predominance of SHV-5 β-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina  S. Uzunovic-Kamberovic,
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy  R.E. Mendes, T. Spanu, L. Deshpande, M. Castanheira,
Multidrug resistance-encoding plasmid from Aeromonas sp. strain P2GI
Comparison of PCR-based methods for typing Escherichia coli
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Typing of Clostridium difficile
D.A. Robinson, M.C. Enright  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
The future of diagnostic bacteriology
Presentation transcript:

The cyclohexane tolerance and Phe-Arg-b-naphtylamide susceptibility of multidrug- resistant Enterobacter cloacae clinical isolates, and the predominance of one PFGE clone in Hungary  K. Glatz, A. Tó th, J. Pászti  Clinical Microbiology and Infection  Volume 17, Issue 8, Pages 1254-1261 (August 2011) DOI: 10.1111/j.1469-0691.2010.03408.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 The Pearson's tree diagram prepared for the 40 PFGE strains of type A (Fig. 1) shows the three clusters that could be distinguished by the Dice analysis as well (Pearson's clusters 1-2-4), and a novel cluster, containing only three isolates (Pearson's cluster3); clusters are separated by a black broken line. The similarity by the Dice coefficient was no more than ≥66% for the 40 PFGE strains, but the similarities (Dice analysis) for the PFGE strains of Pearson's clusters 1-2-4 and for the PFGE strains of Pearson's clusters 1–3 were found to be ≥74% and ≥72%, respectively, indicating the monoclonal origin of type-A isolates [14]. The black scattered line is indicative of 50% similarity (Pearson's analysis). The grey arrow shows the cut of the tree made for PFGE examinations with SpeI. SpeI PFGE was performed on the first isolate of each branch. Places of origin of these isolates are indicated on the tree at the section points (Bp1: HF1, Bp2: HF2, Bp4: HF4, Bp5: HF5, Nó grád1: HF7, BAZ2: HF12, Heves1: HF16, Veszprém1: HF21). Bp, Budapest; BAZ, Borsod-Abaúj-Zemplén. Clinical Microbiology and Infection 2011 17, 1254-1261DOI: (10.1111/j.1469-0691.2010.03408.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 SpeI hierarchical tree diagram. Dice tree for the selected isolates (n = 10) and the Lambda concatemers (used as standards). Lane 1: XbaI Pearson's cluster1 isolate (Bp2, 1998). Lane 2: the first isolate from the XbaI Pearson's cluster3 (Hevesl, 2003). Lane 3: the second isolate of the XbaI Pearson's cluster2 (Bp4, 1998). Lane 4: the first provincial isolate (Nó grádl, 2001, XbaI-Pearson's cluster4). Lane 5: XbaI Pearson's cluster2 isolate (BAZ2, 2002). Lane 6: the first isolate of the XbaI Pearson's cluster2 (Bp2, 1998). Lane 7: the first isolate of the first cluster of cases (Bp5, 2000, XbaIPearson's clusterl). Lane 8: the second isolate from the XbaI Pearson's cluster3 (Veszpréml, 2004). Lanes 9 and 10: the first and the second isolates of ERIC-type A (Bpl, Bp2, XbaI-Pearson's clusterl, 1997–1998). Lanes 11 and 12: Lambda concatemers. (Lane numbering: sequentially from above.) Clinical Microbiology and Infection 2011 17, 1254-1261DOI: (10.1111/j.1469-0691.2010.03408.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions